FR4630M - - Google Patents
Info
- Publication number
- FR4630M FR4630M FR19961A FR19961A FR4630M FR 4630 M FR4630 M FR 4630M FR 19961 A FR19961 A FR 19961A FR 19961 A FR19961 A FR 19961A FR 4630 M FR4630 M FR 4630M
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
- C07D339/02—Five-membered rings
- C07D339/04—Five-membered rings having the hetero atoms in positions 1 and 2, e.g. lipoic acid
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR19961A FR4630M (en) | 1965-06-09 | 1965-06-09 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR19961A FR4630M (en) | 1965-06-09 | 1965-06-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FR4630M true FR4630M (en) | 1966-11-28 |
Family
ID=8581227
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR19961A Expired FR4630M (en) | 1965-06-09 | 1965-06-09 |
Country Status (1)
| Country | Link |
|---|---|
| FR (1) | FR4630M (en) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0318891A1 (en) * | 1987-12-04 | 1989-06-07 | ASTA Medica Aktiengesellschaft | Injectable solution of thioctic acid containing trometamole and/or basic amino acids |
| EP0702953A2 (en) | 1994-09-22 | 1996-03-27 | ASTA Medica Aktiengesellschaft | Dosage form comprising alpha-lipoic acid or solid salts thereof with improved bioavailability |
| WO1999055331A1 (en) * | 1998-04-25 | 1999-11-04 | Skw Trostberg Aktiengesellschaft | Use of alpha lipoic acid to reduce appetite and/or body weight |
| WO2000053176A1 (en) * | 1999-03-05 | 2000-09-14 | Uni-Ci S.R.L. | Pharmaceutic, dietetic and cosmetic compositions based on thioctic acid and cysteine |
| FR2791571A1 (en) * | 1999-04-02 | 2000-10-06 | Sod Conseils Rech Applic | Compositions containing nitrogen monoxide synthase inhibitor and dithiol having metabolic antioxidant activity, useful for treating cardio and cerebrovascular disorders, inflammatory disorders or auto-immune diseases |
| WO2001085165A2 (en) * | 2000-05-10 | 2001-11-15 | Basf Aktiengesellschaft | Combination of lipoic acid and c1 donors for the treatment of disorders of the central nervous system |
| WO2002030918A2 (en) * | 2000-10-10 | 2002-04-18 | Laboratorio Chimico Internazionale S.P.A. | PROCESS FOR THE PRODUCTION OF R(+)α-LIPOIC ACID |
| WO2003099806A1 (en) * | 2002-05-27 | 2003-12-04 | Licrea S.R.L. | Creatine salt having enhanced nutritional, antioxidant and therapeutic efficacy and compositions containing same |
| CN104387364A (en) * | 2014-12-15 | 2015-03-04 | 南京工业大学 | L-ornithine lipoic acid compound salt, and preparation method and application thereof |
-
1965
- 1965-06-09 FR FR19961A patent/FR4630M/fr not_active Expired
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0318891A1 (en) * | 1987-12-04 | 1989-06-07 | ASTA Medica Aktiengesellschaft | Injectable solution of thioctic acid containing trometamole and/or basic amino acids |
| EP0702953A2 (en) | 1994-09-22 | 1996-03-27 | ASTA Medica Aktiengesellschaft | Dosage form comprising alpha-lipoic acid or solid salts thereof with improved bioavailability |
| WO1999055331A1 (en) * | 1998-04-25 | 1999-11-04 | Skw Trostberg Aktiengesellschaft | Use of alpha lipoic acid to reduce appetite and/or body weight |
| WO2000053176A1 (en) * | 1999-03-05 | 2000-09-14 | Uni-Ci S.R.L. | Pharmaceutic, dietetic and cosmetic compositions based on thioctic acid and cysteine |
| WO2000059448A3 (en) * | 1999-04-02 | 2001-03-08 | Sod Conseils Rech Applic | Association of no-synthase inhibitor(s) and metabolic antioxidant(s) |
| WO2000059448A2 (en) * | 1999-04-02 | 2000-10-12 | Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) | Association of no-synthase inhibitor(s) and metabolic antioxidant(s) |
| FR2791571A1 (en) * | 1999-04-02 | 2000-10-06 | Sod Conseils Rech Applic | Compositions containing nitrogen monoxide synthase inhibitor and dithiol having metabolic antioxidant activity, useful for treating cardio and cerebrovascular disorders, inflammatory disorders or auto-immune diseases |
| WO2001085165A2 (en) * | 2000-05-10 | 2001-11-15 | Basf Aktiengesellschaft | Combination of lipoic acid and c1 donors for the treatment of disorders of the central nervous system |
| WO2001085165A3 (en) * | 2000-05-10 | 2002-05-02 | Basf Ag | Combination of lipoic acid and c1 donors for the treatment of disorders of the central nervous system |
| WO2002030918A2 (en) * | 2000-10-10 | 2002-04-18 | Laboratorio Chimico Internazionale S.P.A. | PROCESS FOR THE PRODUCTION OF R(+)α-LIPOIC ACID |
| WO2002030918A3 (en) * | 2000-10-10 | 2002-08-01 | Laboratorio Chimico Int Spa | PROCESS FOR THE PRODUCTION OF R(+)α-LIPOIC ACID |
| WO2003099806A1 (en) * | 2002-05-27 | 2003-12-04 | Licrea S.R.L. | Creatine salt having enhanced nutritional, antioxidant and therapeutic efficacy and compositions containing same |
| CN104387364A (en) * | 2014-12-15 | 2015-03-04 | 南京工业大学 | L-ornithine lipoic acid compound salt, and preparation method and application thereof |